18F-FDG PET/CT plays a unique role in the management of Takayasu arteritis patients with atypical manifestations
- 19 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 40 (2), 625-633
- https://doi.org/10.1007/s10067-020-05028-0
Abstract
Objective The present study aimed to evaluate the value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) aiding in diagnosing and evaluating disease activity in Takayasu arteritis (TA) patients with atypical clinical manifestations. Methods A retrospective study of 22 TA patients was conducted. All the participants were classified into two groups. Group one including 12 patients, who did not fulfill American College of Rheumatology (ACR) criteria, were diagnosed by modified Ishikawa criteria. Group two involving ten patients, who did not satisfy the modified Ishikawa criteria or ACR criteria, were clinically diagnosed as TA after panel discussion by a combination of clinical data, excluding other diagnoses. PET/CT results were analyzed using quantitative and qualitative metrics. Disease activity was evaluated using the US National Institutes of Health (NIH) criteria. Results In group one, nine patients in active stage and two patients in inactive stage had active FDG uptake. One patient in inactive stage had inactive PET/CT results. In group two, five patients in active stage had active FDG uptake and five patients in inactive stage had inactive FDG uptake with SUVmax values of several vascular lesions slightly lower than livermean in each person. The sensitivity of PET/CT scans for evaluating disease activity was 100.0%, specificity was 75.0%, positive predictive value was 87.5%, and negative predictive value was 100.0% compared to NIH criteria. Conclusions PET/CT plays a unique role in diagnosing these TA with atypical manifestation and assisting in evaluating disease activity. Key Points • Diagnosis of these TA patients with atypical manifestations may be difficult. • PET/CT plays a unique role in diagnosing these TA patients and assisting in evaluating disease activity.Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China (81770504)
This publication has 34 references indexed in Scilit:
- Takayasu arteritis: A distinct syndrome of large vessel vasculitis: A view point by late Professor Paul BaconInternational Journal of Rheumatic Diseases, 2019
- 18F‐Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel VasculitisArthritis & Rheumatology, 2017
- F-18 FDG PET/CT in the evaluation of Takayasu arteritis: An experience from the tropicsJournal of Nuclear Cardiology, 2014
- Diagnostic and classification criteria of Takayasu arteritisJournal of Autoimmunity, 2014
- Tocilizumab for the treatment of large‐vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumaticaArthritis Care & Research, 2012
- Role of FDG PET-CT in Takayasu Arteritis: Sensitive Detection of RecurrencesJACC: Cardiovascular Imaging, 2012
- Takayasu's arteritisThe Lancet, 2000
- Diagnostic criteria for Takayasu arteritisInternational Journal of Cardiology, 1996
- The American College of Rheumatology 1990 criteria for the classification of takayasu arteritisArthritis & Rheumatism, 1990
- Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathyJournal of Invasive Cardiology, 1988